We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas. (Z0105)

This study has been terminated.
(Inability to recruit in time a sufficient number of patients)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00354822
First Posted: July 20, 2006
Last Update Posted: September 18, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Regional Hospital of Bolzano
Information provided by:
A.O. Ospedale Papa Giovanni XXIII
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2009
  Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Publications: